Menu

QTY Code: A Tool for Designing Detergent-Free Membrane Proteins and Beyond

NanoTemper Technologies invites you to join them for an educational webinar.

Sep 4, 2019
The Scientist Creative Services Team

FREE Webinar

Tuesday, October 22, 2019
11:00 AM - 12:30  PM Eastern Time

Register Now

G-protein coupled receptors (GPCRs), a class of membrane proteins, are involved in critical cellular signaling pathways that are linked to the onset and cause of many diseases. Determining the structure and function of membrane proteins can be challenging, partly due to their hydrophobic properties, which make solubilization difficult. QTY variants have 46-56 percent of their transmembrane α-helices altered, but they are water-soluble, maintain stable structures, are biologically functional, and retain proper ligand-binding activity.

In this webinar sponsored by NanoTemper Technologies, the creator of QTY code technology, Shuguang Zhang, will share QTY applications and how Prometheus—technology for precisely measuring protein unfolding, chemical denaturation, and aggregation—may be used to look at difficult-to-characterize targets, such as amyloids and other disease-related molecules. Silvia Würtenberger of NanoTemper Technologies will share why Prometheus is the new gold standard for protein stability characterization as it tracks thermal and chemical unfolding, as well as aggregation, all in a label-free way.

Topics to be covered:

  • How QTY code technology systematically replaces hydrophobic amino acids in 7 transmembrane α-helices of GPCRs
  • Applying the QTY code technology to decipher the function of membrane proteins
  • Examining protein stability using Prometheus

Register Now

Meet the Speakers:

Shuguang Zhang, PhD
MIT Media Lab
Massachusetts Institute of Technology




Silvia Würtenberger, PhD
Product Manager, Prometheus
NanoTemper Technologies

 

October 2019

Brain Fog

Air Pollution May Cause Cognitive Decline

Marketplace

Sponsored Product Updates

Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months - Case study to be presented at 2019 ISPE Annual Meeting 
Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months - Case study to be presented at 2019 ISPE Annual Meeting 
·        Lonza has partnered with Nephron Pharmaceuticals Corporation to implement Lonza’s next-generation MODA-ES™ EBR Platform to streamline manufacturing compliance reporting· The MODA-ES™ Platform was implemented at Nephron in an aggressive nine-month time frame, improving operational efficiency and enabling a significant product line expansion·        Full results of the collaboration will be co-presented by Lonza and Nephron at the 2019 ISPE Annual Meeting & Expo in Las Vegas, Nevada
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Understanding T-cell polyfunctionality: How single cell proteomics data drive CAR-T cell therapy research and development
Vladimir Senyukov, Director of BioAnalytical Development at Precision Biosciences, talks about investigating T-cell cytokine production using single cell proteomics in order to unlock the therapeutic potential of allogenic CAR-T cells.
Zymo Research launches new RNA-Seq library prep kit
Zymo Research launches new RNA-Seq library prep kit
Zymo Research is excited to announce the fastest and easiest total RNA-Seq library prep kit that allows users to go from sample to sequencer in a single day!